Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?-Reference-Cited by-同舟云学术

Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?

Published:2022 Issue:2 Volume:62 Page:99-105
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Nishimura Yoshito¹,Nishikori Asami²,Sawada Haruki³,Czech Torrey³,Otsuka Yuki¹,Nishimura Midori Filiz⁴,Mizuno Hiroki⁵,Sawa Naoki⁵,Momose Shuji⁶,Ohsawa Kumiko²,Otsuka Fumio¹,Sato Yasuharu⁴

Affiliation:

1. Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan,

2. Division of Pathophysiology, Okayama University Graduate School of Health Sciences, Okayama, Japan,

3. Department of Medicine, University of Hawaii, Honolulu, HI, USA,

4. Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,

5. Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan,

6. Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/62/2/62_21038/_pdf

Reference38 articles.

1. 1 Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020; 135: 1353-1364.

2. 2 Fajgenbaum DC, Uldrick TS, Bagg A et al. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood. 2017; 129: 1646-1657.

3. 3 Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: where are we now? Semin Diagn Pathol. 2016; 33: 294-306.

4. 4 Takai K, Nikkuni K, Shibuya H, Hashidate H. [Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly]. Rinsho Ketsueki. 2010; 51: 320-325.

5. 5 Kojima M, Nakamura S, Shimizu K et al. Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol. 2004; 12: 25-30.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary;Pathology and Oncology Research;2024-08-26

2. TAFRO Syndrome: A Syndrome or a Subtype of Multicentric Castleman Disease?;Biomedicines;2024-03-14

3. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease;Journal of Clinical Pathology;2024-02-20

4. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease;International Journal of Molecular Sciences;2022-09-07

5. Historical and pathological overview of Castleman disease;Journal of Clinical and Experimental Hematopathology;2022